13F Insight
DOSSIER · 13F-HR · Q1 2026

ABG-WTT Global Life Science Capital Partners GP Ltd

$12M in tracked AUM across 2 positions as of Q1 2026.

AG
CIK 0001832108 · last filed Mar 31, 2026
Total AUM
$12M
as of Q1 2026
Holdings
2
—
positions
Whale Score
61
61
tracked
Activity
—
no data
changes this Q
AI Analysis · Q1 2026
Portfolio Overview

ABG-WTT Global Life Science Capital Partners GP Ltd reports a compact, highly concentrated long equity portfolio worth $18.68 million as of 2025-09-30. The filing lists only two positions and no trading activity during the quarter (no new, sold, increased or reduced stakes). The fund’s reported portfolio value fell 30.2% vs. the prior quarter — an absolute decline of $8.08 million (from $26.76M to $18.68M). The combination of very small number of holdings and a large quarter...

Key Holdings

Two equities account for 100% of the portfolio value:

  • Ceribell, Inc. — Value: $12.50M; Shares: 1.09M; Weight: 66.94% of the portfolio. Implied per-share value in this filing = $12.50M / 1.09M ≈ $11.47 per share.
  • Rapid Micro Biosystems, Inc. — Value: $6.17M; Shares: 1.85M; Weight: 33.06% of the portfolio. Implied per-share value in this filing = $6.17M / 1.85M ≈ $3.34 per share.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
CBLL
CERIBELL INC
$8M442K65.9%02
RPID
RAPID MICRO BIOSYSTEMS INC
$4M1.8M34.1%

Filing history

2026Q1Mar 31
$12M▼ 18.3%
2 positionsView →2025Q4Dec 31
$15M▼ 19.4%
2 positionsView →2025Q3Sep 30
$19M▼ 30.2%
2 positionsView →2025Q2Jun 30
$27M▲ 3.8%
2 positionsLocked2025Q1Mar 31
$26M▼ 41.0%
2 positionsLocked2024Q4Dec 31
$44M▲ 117.3%
4 positionsLocked2024Q3Sep 30
$20M▼ 32.9%
3 positionsLocked2024Q2Jun 30
$30M▼ 27.8%
3 positionsLocked2024Q1Mar 31
$42M▼ 19.1%
3 positionsLocked2023Q4Dec 31
$51M▲ 146.2%
4 positionsLocked2023Q3Sep 30
$21M▲ 278.1%
4 positionsLocked2023Q2Jun 30
$6M▼ 13.1%
3 positionsLocked
Showing 12 of 22